Research

Pharmacological targets in inflammation and metabolic diseases

Search publications

Publications

  • Salvadó L, Palomer FX, Barroso E and Vazquez M.

    Targeting endoplasmic reticulum stress in insulin resistance.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 26(8): 438-448. Number of citations: 170

    [doi:10.1016/j.tem.2015.05.007]

  • Mitjans M, Catalán R, Vazquez M, González-Rodríguez A, Penadés R, Pons A, Massana G, Munro J, Arranz MJ and Arias B.

    Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes.

    PHARMACOGENET GENOM . 25(5): 274-277. Number of citations: 18

    [doi:10.1097/FPC.0000000000000132]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya-Gombau F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Number of citations: 138

    [doi:10.1152/ajpendo.00362.2014]

  • Barroso E, Rodríguez-Rodríguez R, Chacón MR, Maymó-Masip E, Ferrer L, Salvadó L, Salmerón E, Wabistch M, Palomer FX, Vendrell J, Wahli W and Vazquez M.

    PPARß/d ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(5): 1049-1058. Number of citations: 19

    [doi:10.1016/j.bbadis.2015.02.010]

  • Chehaibi K, Cedó L, Metso J, Palomer FX, Santos D, Quesada H, Naceur Slimane M, Wahli W, Julve J, Vazquez M, Jauhiainen M, Blanco-Vaca F and Escolà-Gil JC.

    PPAR-ß/d activation promotes phospholipid transfer protein expression.

    BIOCHEMICAL PHARMACOLOGY . 94(2): 101-108. Number of citations: 23

    [doi:10.1016/j.bcp.2015.01.016]